Nabriva Therapeutics plc Operating Lease, Payments
Nabriva Therapeutics plc reported Operating Lease, Payments of $507.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2021-03-11
- Nabriva Therapeutics plc operating lease, payments for the quarter ending 2020-12-31 was $128.00K, a 1.59% increase year-over-year.
- Nabriva Therapeutics plc operating lease, payments for the quarter ending 2020-09-30 was $127.00K, a 1.60% increase year-over-year.
- Nabriva Therapeutics plc operating lease, payments for the quarter ending 2020-06-30 was $126.00K, a 17.65% decline year-over-year.
- Nabriva Therapeutics plc operating lease, payments for the quarter ending 2020-03-31 was $126.00K, a 13.51% increase year-over-year.
- Nabriva Therapeutics plc operating lease, payments for fiscal 2020 was $507.00K, a 1.55% decline from fiscal 2019.
- Nabriva Therapeutics plc operating lease, payments for fiscal 2019 was $515.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $255.00K derived: sum of 2 quarters · filed 2021-03-11 | $381.00K derived: sum of 3 quarters · filed 2021-03-11 | $507.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $253.00K derived: sum of 2 quarters · filed 2020-11-05 | $379.00K 10-Q · filed 2020-11-05 | $505.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $252.00K 10-Q · filed 2020-08-06 | $378.00K derived: sum of 3 quarters · filed 2021-03-11 | $503.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2020-03-31 | $126.00K 10-Q · filed 2020-05-11 | $252.00K derived: sum of 2 quarters · filed 2021-03-11 | $377.00K derived: sum of 3 quarters · filed 2021-03-11 | $530.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $251.00K derived: sum of 2 quarters · filed 2021-03-11 | $404.00K derived: sum of 3 quarters · filed 2021-03-11 | $515.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $278.00K derived: sum of 2 quarters · filed 2019-11-12 | $389.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $264.00K 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $111.00K 10-Q · filed 2019-05-10 |